Prevalence of autoimmune diabetes among Aboriginal Australians: the Fremantle Diabetes Study Phase <scp>II</scp>
The prevalence of autoimmune diabetes was assessed in 113 indigenous and 1555 non-indigenous participants in the Fremantle Diabetes Study Phase II. Both type 1 diabetes (3.5% vs. 8.2%) and latent autoimmune diabetes of adults diagnosed based on glutamic acid decarboxylase antibody (GADA) positivity (1.0% vs. 5.7%) were lower in Aboriginal participants (P = 0.101 and 0.039 respectively). Six Aboriginals with GADA-negative type 2 diabetes were positive for tyrosine phosphatase-related islet antigen 2 antibodies but did not exhibit relative insulin deficiency.
Authors
- S. A. Paul Chubb (ORCID: https://orcid.org/0000-0002-6742-4110)
- Wendy A. Davis (ORCID: https://orcid.org/0000-0002-5709-8235)
- Timothy M. E. Davis (ORCID: https://orcid.org/0000-0003-0749-7411)
- Christine Bundell (ORCID: https://orcid.org/0000-0002-6372-1513)
- Daniel R. McAullay (ORCID: https://orcid.org/0000-0002-0651-899X)
Institutions
- Edith Cowan University (AU)
- The University of Western Australia (AU)
- Fiona Stanley Hospital (AU)
- Fremantle Hospital (AU)
- Queen Elizabeth II Medical Centre (AU)
- Pathwest Laboratory Medicine (AU)
Publication Details
- Journal
- Internal Medicine Journal
- Published
- 2025-03-18
- DOI
- https://doi.org/10.1111/imj.70029
- Citations
- 1
- Primary Topic
- Diabetes and associated disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.82
Funders
- Medical Research Council
- National Health and Medical Research Council